MIBR

MIBR (Microbiome Research) is a biotechnology company focused on decoding the human microbiome to develop novel diagnostic and therapeutic solutions. The company utilizes advanced sequencing technologies and bioinformatics to analyze microbial ecosystems and their impact on human health. MIBR's primary focus is on identifying microbial signatures associated with chronic conditions such as inflammatory bowel disease and metabolic disorders. By leveraging these insights, the company aims to develop personalized live biotherapeutic products and precision nutrition strategies. MIBR operates at the intersection of microbiology, data science, and clinical medicine to translate microbiome research into actionable healthcare interventions.